维普期刊资源整合服务平台（V6.5）

35篇 您的检索式：作者名="jansen TL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	《2015年美国风湿病学会/欧洲抗风湿联盟痛风分类标准》摘译显示文摘痛风是以尿酸钠(monosodium urate,MSU)结晶在关节液和组织中沉积为特点的疾病,是最常见的关节炎。各国痛风患病率分别为美国3.9%、法国0.9%、英国1.4%-2.5%、德国1.4%,新西兰欧裔和毛利人分别为3.2%和6.1%。在过去的10年中,已有治疗痛风的新药面世或正在进行临床试验。无论是药物临床试验、痛风危险因素观察性研究、	张冰清盛峰谷俊杰杨丹梁广宇张昀曾学军 Neogi T Jansen TL Dalbeth N	2015	中华临床免疫和变态反应杂志2015，9，4：	322
2	A randomised con-trolled trial on the efficacy and tolerability with dose escalation ofallopurinol 300-600 mg/day versus benzbromarone 100-200 mg/day in patients with gout显示文摘	Reinders MK Haagsma C Jansen TL	2009	Ann Rheum Dis2009，68，6：	1
3	Gout: why is this curable disease so seldom cured? 显示文摘	Doherty M Jansen TL Nuki G	2012	Ann Rheum Dis2012，71，11：	1
4	2015 Gout Classification Criteria:an American College of RheumatologyEuropean League Against Rheumatism Collaborative Initiative显示文摘	Neogi T Jansen TL Dalbeth N	2015	Arthritis Rheumatol2015，67，：	1
5	Survey on management of gout among Dutch rheumatologists显示文摘	Reinders MK Jansen TL	2008	Ann Rheum Dis2008，67，7：	1
6	A randomised con-trolled trial on the efficacy and tolerability with dose escalation of allopurinol300-600mg/day versus benzbromarone100-200mg/day in patients with gout显示文摘	Reinders MK Haagsma C Jansen TL	2009	Ann Rheum Dis2009，68，6：	1
7	Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol 显示文摘	Reinders MK van Roon EN Jansen TL	2009	Ann Rheum Dis2009，68，1：	1
8	Gout current diag-nosis and treatment显示文摘	Tausche AK Jansen TL Schroder HE	2009	Dtsch Arztebl Int2009，106，3435：	1
9	Management of hyperuricemia in gout: focus on febuxostat显示文摘	Reinders MK jansen TL	2010	Clin Interv Aging2010，5，：	1
10	Gout: why is this cura- ble disease so seldom cured? 显示文摘	Doherty M Jansen TL Nuki G	2012	Ann Rheum Dis2012，71，11：	1
11	Somatostatin analog octreotide (SMS 201-995) prevents the decrease in blood pres- sure after oral glucose loading in the elderly显示文摘	Jansen RW Peeters TL Lenders JW	1989	J Clin Endocrinol Metab1989，68，4：	1
12	New classification criteria for gout: a framework for progress 显示文摘	Dalbeth N Fransen J Jansen TL	2013	Rheumatology (Oxford)2013，52，10：	1
13	Gout: why is this curable disease so seldom cured?显示文摘	Doherty M Jansen TL Nuki G	2012	Ann Rheum Dis2012，71，：	1
14	Gout: why is this curable disease so seldom cured? 显示文摘	DOHERTY M JANSEN TL NUKI G	2012	Ann Rheum Dis2012，71，11：	1
15	Efficacy and tolerability of urate-lowering drugs in gout:a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol显示文摘	Reinders MK1 van Roon EN Jansen TL	2009	Ann Rheum Dis2009，681，：	1
16	Somatostatin analog octreotide (SMS 201-995 ) prevents the decrease in blood pressure after oral glucose loading in the elderly 显示文摘	Jansen RW Peeters TL Lenders JW	1989	J Clin Endocrinol Metab1989，68，4：	1
17	Benzbromarone withdrawn from the European market:another case of 'absence of evidence is evidence of absence'?显示文摘	Jansen TL Reinders MK van Roon EN	2004	Clin Exp Rheumatol2004，22，5：	1
18	The influence of food temperature on postprandial blood pressure reduction and its relation to substance-P in healthy elderly subjects 显示文摘	Kuipers HM Jansen RW Peeters TL	1991	J Am Geriatr Sac1991，39，2：	1
19	Risk assessment for osteoporosis by quantitative ultrasound of the heel in ankylosing spondylitis显示文摘	Jansen TL Aarts MH Zanen S	2003	Clin Exp Rheumatol2003，21，5：	1
20	Gout-current d-iagnos is and treatment显示文摘	Tausche AK Jansen TL Schrêder HE	2009	Dtsch Arztebl Int2009，106，34：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示